Intravitreal Injections by Nurses and Physicians Compared

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

328 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anti-VEGF agents are given for a variety of previously untreatable eye diseases. The last years indications for their use and consequently the number of patients needing treatment, have been increasing. Most patients require multiple injections. This has resulted in many eye departments administering thousands of injections per year, also at St Olavs University Hospital Trondheim. To cope with this increase in workload, it would be helpful if injections would be given not only by the physicians but also by the nurses. This study's objective is to compare efficiency, patient satisfaction and cost per patient of injections given by nurses and physicians.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effectiveness of Intravitreal Avastin Injection for CRVO

NCT01678248

Central Retinal Vein Occlusion

UNKNOWN

Effect of Video Viewing on Intravitreal Injection Experience

NCT07002372

RECRUITING NA

The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram

NCT00478530

Macular Degeneration

COMPLETED NA

Study of the Long-Term Effect of Frequent Anti-VEGF Dosing on Retinal Function in Patients With Neovascular AMD

NCT00533689

Electrophysiology

UNKNOWN PHASE3

Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration

NCT03680326

Vitreomacular Interface

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eye Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

nurse

intravitreal injections with anti-VEGF agents given by a nurse

Group Type EXPERIMENTAL

intravitreal injections given by a nurse

Intervention Type PROCEDURE

Intravitreal injections

Intervention Type PROCEDURE

Anti-VEGF agents

Intervention Type DRUG

physician

intravitreal injections with anti-VEGF agents given by a physician

Group Type ACTIVE_COMPARATOR

intravitreal injections given by a physician

Intervention Type PROCEDURE

Intravitreal injections

Intervention Type PROCEDURE

Anti-VEGF agents

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intravitreal injections given by a nurse

Intervention Type PROCEDURE

intravitreal injections given by a physician

Intervention Type PROCEDURE